Co-Founder & CEO

Chief Financial Officer

AstraZeneca Racks Up AI Partners, Seeking To Stop Cancer at All Stages

The Healthcare Technology Report Announces The Top 25 Healthcare AI Executives of 2025

Verge Genomics selects new development candidate for long-term weight management

Verge Genomics Announces New Development Candidate, VRG201, a Novel Maintenance Therapy for Long-Term Weight Management

Computational Biologist (AI/ML)

Verge Genomics is dedicated to accelerating drug development through the use of artificial intelligence and human data. The Computational Biologist (AI/ML) will work closely with the platform and computational biology teams to define and enable new product offerings, leveraging the company's proprietary drug discovery engine for various stakeholders.

Sign up with Google

Sign in with Google